Diagnosis & Detection
Hall, S. Ohrfelt, A. Constantinescu, R. [et al]. (2012). Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and / or parkinsonian disorders. Archives of Neurology. November 2012; 69(11): 1445-52.
Cochrane, C.J. [and] Ebmeier, K.P. (2013). Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology. February 26th 2013; 80(9): 857-64. Review.
Falls
Allen, N.E. Schwarzel, A.K. [and] Canning, C.G. (2013). Recurrent falls in Parkinson’s disease: a systematic review. Parkinson’s Disease. March 15th 2013; 906274. Full Text Link.
Genetics
Ahmed, I. Tamouza, R. Delord, M. [et al]. (2012). Association between Parkinson’s disease and the HLA-DRB1 locus. Movement Disorders. August 2012; 27(9): 1104-10.
Dumitriu, A. Latourelle, J.C. Hadzi, T.C. [et al]. (2012). Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation. PLoS Genetics. June 2012; 8(6): e1002794. Full Text Link.
Wu, Y. Wang, X. Xu, W. [et al]. (2012). Genetic variation in LINGO-1 (rs9652490) and risk of Parkinson’s disease: twelve studies and a meta-analysis. Neuroscience Letters. July 26th 2012; 522(1):67-72.
Allen, M. Zou, F. Chai, H.S. [et al]. (2012). Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Molecular Neurodegeneration. April 11th 2012; 7: 13. Full Text Link.
Mao, X. Wang, T. Peng, R. [et al]. (2013). Mutations in GBA and risk of Parkinson’s disease: a meta-analysis based on 25 casecontrol studies. Neurological Research. May 14th 2013. [Epub ahead of print].
Balafkan, N. Tzoulis, C. Muller, B. [et al]. (2012). Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population. Mitochondrion. November 2012; 12(6): 640-3.
Kilarski, L.L. Pearson, J.P. Newsway, V. [et al]. (2012). Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society. October 2012; 27(12): 1522-9.
Hudson, G. Nalls, M. Evans, J.R. [et al]. (2013). Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology. May 28th 2013; 80(22): 2042-2048.
Keller, M.F. Saad, M. Bras, J. [et al]; International Parkinson’s Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2). (2012). Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease. Human Molecular Genetics. November 15th 2012; 21(22): 4996-5009.
General / Miscellaneous
Hermanns, M. Deal, B. [and] Haas, B. (2012). Biopsychosocial and spiritual aspects of Parkinson disease: an integrative review. Journal of Neuroscience Nursing. August 2012; 44(4): 194-205. Review.
Johnson, S.J. Diener, M.D. Kaltenboeck, A. [et al]. (2013). An economic model of Parkinson’s disease: implications for slowing progression in the United States. Movement Disorders: Official Journal of the Movement Disorder Society. March 2013; 28(3): 319-26.
Willis, G.L. Moore, C. [and] Armstrong, S.M. (2012). A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson’s disease. Reviews in the Neurosciences. March 1st 2012; 23(2): 199-226.
Noyce, A.J. Bestwick, J.P. Silveira-Moriyama, L. [et al]. (2012). Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Annals of Neurology. December 2012; 72(6): 893-901. Review. Full Text Link.
Hindle, J.V. Petrelli, A. Clare, L. [et al]. (2013). Nonpharmacological enhancement of cognitive function in Parkinson’s disease: a systematic review. Movement Disorders. February 20th 2013. [Epub ahead of print].
Crizzle, A.M. Classen, S. [and] Uc, E.Y. (2012). Parkinson disease and driving: an evidence-based review. Neurology. November 13th 2012; 79(20): 2067-74. Review.
Yang, S. Sajatovic, M. [and] Walter, B.L. (2012). Psychosocial interventions for depression and anxiety in Parkinson’s disease. Journal of Geriatric Psychiatry and Neurology. June 2012; 25(2): 113-21. Review.
Gazibara, T. Stankovic, I. Tomic, A. [et al]. (2013). Validation and cross-cultural adaptation of the Self-Assessment Disability Scale in patients with Parkinson’s disease in Serbia. Journal of Neurology. April 7th 2013. [Epub ahead of print].
Munoz-Hellin, E. Cano-de-la-Cuerda, R. [and] Miangolarra-Page, J.C. (2013). [Visual cues as a therapeutic tool in Parkinson’s disease. A systematic review.]. Revista Espanola Geriatria Gerontologia. June 1st 2013. [Epub ahead of print]. Spanish.
Pharmacological Treatments
Viallet, F. Pitel, S. Lancrenon, S. [et al]. (2013). Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson’s disease. Current Medical Research and Opinion. January 2013; 29(1): 23-31.
Kim, T.H. Cho, K.H. Jung, W.S. [et al]. (2012). Herbal medicines for Parkinson’s disease: a systematic review of randomized controlled trials. PLoS One. 2012; 7(5): e35695. Review. Full Text Link.
Minguez-Minguez, S. Pozo, J.S. [and] Jordan, J. (2013). Rasagiline in Parkinson’s disease: A review based on meta-analysis of clinical data. Pharmacological Research. June 1st 2013. [Epub ahead of print].
Physiotherapy / Occupational Therapy
Lima, L.O. Scianni, A. [and] Rodrigues-de-Paula, F. (2013). Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson’s disease: a systematic review. Journal of Physiotherapy. 2013; 59(1): 7-13.
van Nimwegen, M. Speelman, A.D. Overeem, S. [et al]; ParkFit Study Group (2013). Promotion of physical activity and fitness in sedentary patients with Parkinson’s disease: randomised controlled trial. BMJ. March 1st 2013; 346: f576. Full Text Link.
Wittwer, J.E. Webster, K.E. [and] Hill, K. (2013). Rhythmic auditory cueing to improve walking in patients with neurological conditions other than Parkinson’s disease: what is the evidence? Disability and Rehabilitation. January 2013; 35(2): 164-76.
Rehabilitation / SALT
Smith, S.K. Roddam, H. [and] Sheldrick, H. (2012). Rehabilitation or compensation: time for a fresh perspective on speech and language therapy for dysphagia and Parkinson’s disease? International Journal of Language and Communication Disorders. July – August 2012; 47(4): 351-64.
Research-Related Issues
Carroll, C. Palmer, A. Cosby, C. [et al]. (2012). Analysis and validation of a Parkinson’s disease register as a recruitment tool for clinical studies. Clinical Medicine. June 2012; 12(3): 210-5. Full Text Link.
Elm, JJ.; NINDS NET-PD Investigators. (2012). Design innovations and baseline findings in a long-term Parkinson’s trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson’s Disease Long-Term Study-1. Movement Disorders. October 2012; 27(12): 1513-21.
Fitzsimmons, P.R. Blayney, S. Mina-Corkill, S. [et al]. (2012). Older participants are frequently excluded from Parkinson’s disease research. Parkinsonism & Related Disorders. June 2012; 18(5): 585-9.
Sherer, T.B. Chowdhury, S. Peabody, K. [et al]. (2012). Overcoming obstacles in Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society. November 2012; 27(13): 1606-11.
Risk Factors / Epidemiology / Prevention
Wang, Y. [and] Yang, X. (2012). Association of catechol-o-methyltransferase polymorphism (Val108/158Met) with Parkinson’s disease: a meta-analysis. Journal of Motor Behavior. 2012; 44(5): 365-72.
Irwin, D.J. Abrams, J.Y. Schonberger, L.B. [et al]. (2013). Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurology. April 2013; 70(4): 462-8. Full Text Link.
Pezzoli, G. [and] Cereda, E. (2013). Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. May 28th 2013; 80(22): 2035-41. Full Text Link.
Jafari, S. Etminan, M. Aminzadeh, F. [et al]. (2013). Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Movement Disorders: Official Journal of the Movement Disorder Society. April 22nd 2013. [Epub ahead of print].
Noyce, A.J. Bestwick, J.P. Silveira-Moriyama, L. [et al]. (2012). Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Annals of Neurology. December 2012; 72(6): 893-901. Review. Full Text Link.
Van Maele-Fabry, G. Hoet, P. Vilain, F. [et al]. (2012). Occupational exposure to pesticides and Parkinson’s disease: a systematic review and meta-analysis of cohort studies. Environment International. October 1st 2012; 46: 30-43.
Espinoza, S. Manago, F. Leo, D. [et al]. (2012). Role of catechol-O-methyltransferase (COMT)-dependent processes in Parkinson’s disease and L-DOPA treatment. CNS & Neurological Disorders Drug Targets. May 2012; 11(3): 251-63. Review.
Shen, C. Guo, Y. Luo, W. [et al]. (2013). Serum urate and the risk of Parkinson’s disease: results from a meta-analysis. Canadian Journal of Neurological Sciences. January 2013; 40(1): 73-9.
Lock, E.A. Zhang, J. [and] Checkoway, H. (2013). Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence. Toxicology and Applied Pharmacology. February 1st 2013; 266(3): 345-55. Review.
